(CIPLA:IN) – Analyst Comments
-
PhillipCapital Positive on Indian Pharma: 'Indian Pharma Industry is set to gain from the continuing benefits from specialty products'
-
Cipla Ltd. (CIPLA:IN) PT Raised to INR1,585 at HSBC, 'continue to like Cipla's healthy outlook'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CIPLA:IN Stock Lookup